Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

Eiichi Araki; Yukiko Onishi; Michiko Asano; Hyosung Kim; Ella Ekholm; Eva Johnsson; Toshitaka Yajima

doi:10.1111/jdi.12453

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

Journal of Diabetes Investigation ◽

10.1111/jdi.12453 ◽

2016 ◽

Vol 7 (4) ◽

pp. 555-564 ◽

Cited By ~ 25

Author(s):

Eiichi Araki ◽

Yukiko Onishi ◽

Michiko Asano ◽

Hyosung Kim ◽

Ella Ekholm ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Treatment Period ◽

Interim Analysis ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1441816 ◽

2018 ◽

Vol 34 (6) ◽

pp. 981-994 ◽

Cited By ~ 7

Author(s):

Yutaka Seino ◽

Takashi Sasaki ◽

Atsushi Fukatsu ◽

Hisae Imazeki ◽

Hidekazu Ochiai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Study ◽

Insulin Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind

Download Full-text

A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control

Diabetes Obesity and Metabolism ◽

10.1111/dom.14331 ◽

2021 ◽

Author(s):

Takashi Kadowaki ◽

Yutaka Seino ◽

Kohei Kaku ◽

Taro Okamoto ◽

Miho Kameya ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Therapy ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13397 ◽

2018 ◽

Vol 20 (10) ◽

pp. 2490-2493 ◽

Cited By ~ 2

Author(s):

Kohei Kaku ◽

Shingo Kuroda ◽

Kazuyuki Ishida ◽

Yuusuke Umeda

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase Iv

Download Full-text

Decision letter for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v1/review2 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 35

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01222.x ◽

2010 ◽

Vol 12 (8) ◽

pp. 700-708 ◽

Cited By ~ 55

Author(s):

Y. Iwamoto ◽

A. Kashiwagi ◽

N. Yamada ◽

S. Terao ◽

N. Mimori ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12555 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1198-1201 ◽

Cited By ~ 5

Author(s):

K. Kaku ◽

M. Katou ◽

M. Igeta ◽

T. Ohira ◽

H. Sano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

Download Full-text

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v2/review3 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text